Principal Street Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.4M Sell
1,523
-55
-3% -$55.8K 0.23% 68
2025
Q4
$1.7M Sell
1,578
-932
-37% -$891K 0.29% 64
2025
Q3
$1.92M Sell
2,510
-2,787
-53% -$2.07M 0.31% 64
2025
Q2
$4.13M Buy
5,297
+3,018
+132% +$2.35M 0.4% 62
2025
Q1
$1.88M Buy
2,279
+120
+6% +$99.9K 0.35% 60
2024
Q4
$1.67M Sell
2,159
-1,426
-40% -$1.18M 0.33% 57
2024
Q3
$3.23M Buy
3,585
+1,305
+57% +$1.17M 0.53% 58
2024
Q2
$2.06M Sell
2,280
-29
-1% -$23.2K 0.37% 58
2024
Q1
$1.77M Sell
2,309
-288
-11% -$205K 0.33% 59
2023
Q4
$1.51M Sell
2,597
-205
-7% -$120K 0.37% 59
2023
Q3
$1.51M Sell
2,802
-169
-6% -$87.1K 0.3% 66
2023
Q2
$1.39M Sell
2,971
-34
-1% -$14.3K 0.33% 60
2023
Q1
$1.03M Sell
3,005
-848
-22% -$286K 0.26% 68
2022
Q4
$1.41M Sell
3,853
-128
-3% -$45.4K 0.36% 56
2022
Q3
$1.29M Buy
3,981
+286
+8% +$90.6K 0.34% 61
2022
Q2
$1.2M Sell
3,695
-315
-8% -$94.6K 0.31% 61
2022
Q1
$1.15M Buy
4,010
+173
+5% +$44.5K 0.26% 68
2021
Q4
$1.06M Buy
+3,837
New +$973K 0.26% 69

Other funds holding LLY

Principal Street Partners's LLY Position: Q1 2026 in Review

Principal Street Partners reduced its Eli Lilly (LLY) stake by 3.5% in Q1 2026, selling an estimated $55.8K and leaving 1,523 shares worth $1.4M. The position accounts for 0.23% of the portfolio, ranked #68.

Principal Street Partners first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.13M in Q2 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Principal Street Partners held 1,523 shares of Eli Lilly worth $1.4M as of Q1 2026.
  • Principal Street Partners sold 55 Eli Lilly shares in Q1 2026, an estimated $55.8K.
  • Eli Lilly made up 0.23% of Principal Street Partners's portfolio in Q1 2026, its #68 holding.
  • Principal Street Partners first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • Principal Street Partners's Eli Lilly position peaked at $4.13M in Q2 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Principal Street Partners's 13F filing for Q1 2026, filed 15 May 2026.